Wealth Enhancement Advisory Services, LLC Amicus Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 23,883 shares of FOLD stock, worth $214,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,883Holding current value
$214,947% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
306Shares Held
327MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.5MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$262 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$219 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$162 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$132 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.52B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...